Recombinant CD40L (Ruplizumab Biosimilar) antibody

Catalog No. ABIN7597964

Product Details anti-CD40L (Ruplizumab Biosimilar) Antibody

Target: CD40L (Ruplizumab Biosimilar) (CD40LG (Ruplizumab Biosimilar))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Expression System: Mammalian cells

Clonality: Chimeric

Conjugate: This CD40L (Ruplizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Purpose: Research Grade Ruplizumab Biosimilar Antibody

Specificity: SCD40L, Tumor necrosis factor ligand superfamily member 5, T-cell antigen Gp39, CD40L, TNFSF5, CD154, CD40-L, TNF-related activation protein, CD40 ligand, CD40LG, TRAP

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Grade: Research Grade

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD40L (Ruplizumab Biosimilar)

Target: CD40L (Ruplizumab Biosimilar) (CD40LG (Ruplizumab Biosimilar))

Alternative Name: Ruplizumab Biosimilar (CD40LG (Ruplizumab Biosimilar) Products)

Target Type: Biosimilar

Background: SCD40L, Tumor necrosis factor ligand superfamily member 5, T-cell antigen Gp39, CD40L, TNFSF5, CD154, CD40-L, TNF-related activation protein, CD40 ligand, CD40LG, TRAP

UniProt: P29965

CAS-No: 220651-94-5